124 related articles for article (PubMed ID: 11994274)
1. Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells.
Graichen R; Liu D; Sun Y; Lee KO; Lobie PE
J Biol Chem; 2002 Jul; 277(29):26662-72. PubMed ID: 11994274
[TBL] [Abstract][Full Text] [Related]
2. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival.
Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE
J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545
[TBL] [Abstract][Full Text] [Related]
3. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression.
Li PX; Wong J; Ayed A; Ngo D; Brade AM; Arrowsmith C; Austin RC; Klamut HJ
J Biol Chem; 2000 Jun; 275(26):20127-35. PubMed ID: 10777512
[TBL] [Abstract][Full Text] [Related]
4. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.
Tan M; Wang Y; Guan K; Sun Y
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):109-14. PubMed ID: 10618379
[TBL] [Abstract][Full Text] [Related]
5. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.
Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE
Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849
[TBL] [Abstract][Full Text] [Related]
6. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone.
Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE
Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519
[TBL] [Abstract][Full Text] [Related]
7. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
[TBL] [Abstract][Full Text] [Related]
8. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.
Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE
Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309
[TBL] [Abstract][Full Text] [Related]
10. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.
Zhang X; Zhu T; Chen Y; Mertani HC; Lee KO; Lobie PE
J Biol Chem; 2003 Feb; 278(9):7580-90. PubMed ID: 12482855
[TBL] [Abstract][Full Text] [Related]
11. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
[TBL] [Abstract][Full Text] [Related]
12. A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53.
Wong J; Li PX; Klamut HJ
J Biol Chem; 2002 Jul; 277(29):26699-707. PubMed ID: 12011055
[TBL] [Abstract][Full Text] [Related]
13. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE
Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of p53 by Pitx1.
Liu DX; Lobie PE
Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma.
Xu XQ; Emerald BS; Goh EL; Kannan N; Miller LD; Gluckman PD; Liu ET; Lobie PE
J Biol Chem; 2005 Jun; 280(25):23987-4003. PubMed ID: 15845533
[TBL] [Abstract][Full Text] [Related]
16. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of autocrine/paracrine effects of human growth hormone in human mammary carcinoma cells.
Vouyovitch CM; Vidal L; Borges S; Raccurt M; Arnould C; Chiesa J; Lobie PE; Lachuer J; Mertani HC
Adv Exp Med Biol; 2008; 617():493-500. PubMed ID: 18497074
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.
Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581
[TBL] [Abstract][Full Text] [Related]
19. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.
Friedrichsen BN; Richter HE; Hansen JA; Rhodes CJ; Nielsen JH; Billestrup N; Møldrup A
Mol Endocrinol; 2003 May; 17(5):945-58. PubMed ID: 12586844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
